Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

NAR cancer

Showing results (1-10 of 326) with videos related to

Pageof 33
Sort By:
NAR Cancer|May 13, 2021
Top1-PARP1 association and beyond: from DNA topology to break repairSrijita Paul Chowdhuri, Benu Brata Das
NAR Cancer|August 19, 2021
A novel view on an old drug, 5-fluorouracil: an unexpected RNA modifier with intriguing impact on cancer cell fateMounira Chalabi-Dchar, Tanguy Fenouil, Christelle Machon, et al.
NAR Cancer|March 15, 2021
Mutational signatures associated with exposure to carcinogenic microplastic compounds bisphenol A and styrene oxideXiaoju Hu, Antara Biswas, Anchal Sharma, et al.
NAR Cancer|November 22, 2021
NAD<sup>+</sup> bioavailability mediates PARG inhibition-induced replication arrest, intra S-phase checkpoint and apoptosis in glioma stem cellsJianfeng Li, Kate M Saville, Md Ibrahim, et al.
NAR Cancer|November 4, 2021
Can the epigenome contribute to risk stratification for cancer onset?Sophie A Lelièvre
NAR Cancer|October 21, 2022
The limits of molecular signatures for pancreatic ductal adenocarcinoma subtypingManuela Lautizi, Jan Baumbach, Wilko Weichert, et al.
NAR Cancer|October 21, 2022
Escape from G1 arrest during acute MEK inhibition drives the acquisition of drug resistancePrasanna Channathodiyil, Kieron May, Anne Segonds-Pichon, et al.
NAR Cancer|September 30, 2022
<i>PLK3</i> amplification and tumor immune microenvironment of metastatic tumors are linked to adjuvant treatment outcomes in uterine serous cancerWendell Jones, David Tait, Chad Livasy, et al.
NAR Cancer|September 30, 2022
SFPQ promotes RAS-mutant cancer cell growth by modulating 5'-UTR mediated translational control of CK1αVenetia Jing Tong Kok, Jia Ying Tang, Gracie Wee Ling Eng, et al.
NAR Cancer|April 27, 2022
PDXNet portal: patient-derived Xenograft model, data, workflow and tool discoverySoner Koc, Michael W Lloyd, Jeffrey W Grover, et al.
Pageof 33

Showing results (1-10 of 326) with videos related to

Sort By:
Pageof 33
NAR Cancer|May 13, 2021
Top1-PARP1 association and beyond: from DNA topology to break repairSrijita Paul Chowdhuri, Benu Brata Das
NAR Cancer|August 19, 2021
A novel view on an old drug, 5-fluorouracil: an unexpected RNA modifier with intriguing impact on cancer cell fateMounira Chalabi-Dchar, Tanguy Fenouil, Christelle Machon, et al.
NAR Cancer|March 15, 2021
Mutational signatures associated with exposure to carcinogenic microplastic compounds bisphenol A and styrene oxideXiaoju Hu, Antara Biswas, Anchal Sharma, et al.
NAR Cancer|November 22, 2021
NAD<sup>+</sup> bioavailability mediates PARG inhibition-induced replication arrest, intra S-phase checkpoint and apoptosis in glioma stem cellsJianfeng Li, Kate M Saville, Md Ibrahim, et al.
NAR Cancer|November 4, 2021
Can the epigenome contribute to risk stratification for cancer onset?Sophie A Lelièvre
NAR Cancer|October 21, 2022
The limits of molecular signatures for pancreatic ductal adenocarcinoma subtypingManuela Lautizi, Jan Baumbach, Wilko Weichert, et al.
NAR Cancer|October 21, 2022
Escape from G1 arrest during acute MEK inhibition drives the acquisition of drug resistancePrasanna Channathodiyil, Kieron May, Anne Segonds-Pichon, et al.
NAR Cancer|September 30, 2022
<i>PLK3</i> amplification and tumor immune microenvironment of metastatic tumors are linked to adjuvant treatment outcomes in uterine serous cancerWendell Jones, David Tait, Chad Livasy, et al.
NAR Cancer|September 30, 2022
SFPQ promotes RAS-mutant cancer cell growth by modulating 5'-UTR mediated translational control of CK1αVenetia Jing Tong Kok, Jia Ying Tang, Gracie Wee Ling Eng, et al.
NAR Cancer|April 27, 2022
PDXNet portal: patient-derived Xenograft model, data, workflow and tool discoverySoner Koc, Michael W Lloyd, Jeffrey W Grover, et al.
Pageof 33